Never too late to post good news! Dr. Leslie Thompson along with Drs. Beverly Davidson and Jang-Ho Cha received a 2023 $1M Transformative Research Award taking strides towards treatments for…

Never too late to post good news! Dr. Leslie Thompson along with Drs. Beverly Davidson and Jang-Ho Cha received a 2023 $1M Transformative Research Award taking strides towards treatments for…
Thank you to everyone who came out for our first Pickleball Tournament last Saturday, October 12th! We had a fantastic turn out and everyone brought so much great energy. Congrats…
HD-CARE is hosting our first Pickleball Tournament in Memory of the Portillo Children on October 12th! Any level of player is welcome to join as we will have multiple brackets…
The SURVEYOR study is a trial looking at cognitive changes in people with HD and tested short term safety of dalzanemdor. Read article here written by Dr. Leora Fox, edited…
An amazing man, Dimitri Poffé, took life by the horns after testing positive for Huntington's disease. He left France to go on an incredible ride across South America. This documentary exemplifies…
Read now the most updated, comprehensive report relating to market outlook, drug uptake, treatment scenario and epidemiology trends in Huntington's disease. https://www.einnews.com/pr_news/717150718/huntington-s-disease-market-report-2034-epidemiology-data-pipeline-therapies-latest-approvals-by-delveinsight
Dr. Sarah Tabrizi is Director of the UCL Huntington’s Disease Centre and Joint-Head of the Department of Neurodegenerative Disease, at the UCL Queen Square Institute of Neurology. Sarah’s multidisciplinary research…
The journal, Brain, highlights a recent paper on "Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration". A review by Schultz et al., succinctly summarizes intriguing…
HD-CARE supports the UCI Thompson Lab, which is located in the UCI Sue and Bill Gross Stem Cell Research Center (SCRC). The SCRC thanked us for making 2023 an incredible…
Exciting new collaboration between the Huntington's Study Group (HSG) and Roche therapeutics. HSG will advise Roche on recruitment and enrollment of the needs of GENERATION HD2. This work will collectively…